(4-Chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate | 1256565-36-2

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: (4-Chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate
• CAS: 1256565-36-2；1219951-09-3
• 化学式: C₂₅H₂₀Cl₂N₂O₃
• 分子量: 467.3
• InChiKey: SRSHBZRURUNOSM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.3
• 重原子数：
  32
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  54.6
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• ADMINISTRATION OF CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISEASES
  申请人：Cao Liangxian

  公开号：US20070254878A1

  公开（公告）日：2007-11-01

  In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and compositions, and methods for the administration and use of those compounds. provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the treatment of solid tumor cancer, and in reducing serum, plasma, and/or tumor VEGF levels, are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the treatment of cancer, and the reduction of plasma and/or tumor VEGF levels, using the compounds of the invention.

  根据本发明，已经鉴定出了抑制VEGF在转录后表达的化合物，以及这些化合物的组合物、管理和使用方法。在发明的一个方面，提供了在抑制VEGF生产、治疗实体肿瘤癌和减少血清、血浆和/或肿瘤VEGF水平方面有用的化合物。在发明的另一个方面，提供了使用本发明的化合物抑制VEGF生产、治疗癌症和减少血浆和/或肿瘤VEGF水平的方法。
• Carboline Derivatives Useful in the Inhibition of Angiogenesis
  申请人：MOON Young-Choon

  公开号：US20070281962A2

  公开（公告）日：2007-12-06

  In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the inhibition of angiogenesis, and/or in the treatment of cancer, diabetic retinopathy or exudative macular degeneration are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the inhibition of angiogenesis, and/or the treatment of cancer, diabetic retinopathy or exudative macular degeneration using the compounds of the invention.

  根据本发明，已经鉴定出了抑制VEGF转录后表达的化合物，并提供了它们的使用方法。在本发明的一个方面，提供了在抑制VEGF产生、抑制血管生成和/或治疗癌症、糖尿病视网膜病变或渗出性黄斑变性方面有用的化合物。在本发明的另一个方面，提供了使用本发明中的化合物抑制VEGF产生、抑制血管生成和/或治疗癌症、糖尿病视网膜病变或渗出性黄斑变性的方法。
• CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS
  申请人：MOON Young-Choon

  公开号：US20110160190A1

  公开（公告）日：2011-06-30

  In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the treatment of solid tumor cancer, and in reducing plasma and/or tumor VEGF levels, are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the treatment of cancer, and the reduction of plasma and/or tumor VEGF levels, using the compounds of the invention.

  根据本发明，已经确定了抑制VEGF在转录后表达的化合物，并提供了其使用方法。在本发明的一个方面中，提供了用于抑制VEGF产生、治疗实体肿瘤癌和降低血浆和/或肿瘤VEGF水平的化合物。在本发明的另一个方面中，提供了使用本发明的化合物抑制VEGF产生、治疗癌症和降低血浆和/或肿瘤VEGF水平的方法。
• CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISEASES
  申请人：Cao Liangxian

  公开号：US20120129841A1

  公开（公告）日：2012-05-24

  In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and compositions, and methods for the administration and use of those compounds. provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the treatment of solid tumor cancer, and in reducing serum, plasma, and/or tumor VEGF levels, are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the treatment of cancer, and the reduction of plasma and/or tumor VEGF levels, using the compounds of the invention.

  根据本发明，已经鉴定出抑制VEGF转录后表达的化合物，以及这些化合物的组合物、用于管理和使用这些化合物的方法。在本发明的一个方面，提供了在抑制VEGF产生、治疗实体肿瘤癌和减少血清、血浆和/或肿瘤VEGF水平方面有用的化合物。在本发明的另一个方面，提供了使用本发明的化合物抑制VEGF产生、治疗癌症和减少血浆和/或肿瘤VEGF水平的方法。
• PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES
  申请人：Hwang Peter Seongwoo

  公开号：US20120136154A1

  公开（公告）日：2012-05-31

  Provided herein are improved processes for the synthesis of substituted tetrahydro beta-carboline derivatives. In particular, provided herein are improved processes useful for the preparation of (S)-4-chlorophenyl 6-chloro-1-(4-methoxyphenyl)-3,4-dihydro-1H-pyrido[3,4- b ]indole-2(9H)-carboxylate. Formula (I)

  本文提供了改进的过程，用于合成取代的四氢β-咔啉衍生物。具体而言，本文提供了改进的过程，用于制备(S)-4-氯苯基6-氯-1-(4-甲氧苯基)-3,4-二氢-1H-吡啶[3,4-b]吲哚-2(9H)-羧酸酯。化学式(I)